Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015230
Filing Date
2025-06-02
Accepted
2025-06-02 17:06:22
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 form4-06022025_090619.html 4  
1 form4-06022025_090619.xml 4 3927
  Complete submission text file 0001415889-25-015230.txt   5436
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Giordano Michael F (Reporting) CIK: 0001733915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 251016003